References: Edmunds‚ M. W. & Mayhew‚ M. S. (2009). Pharmacology for the primary care provider. St. Louis‚ Mo. Mosby‚ Inc. Merck Manual (2006). The merck manual of diagnosis and therapy. Whitehouse Station‚ NJ. Merck & Co.‚ Inc. Mettler‚ F. A. (2005). Essentials of radiology. Philadelphia‚ PA. Elsevier‚ Inc. Uphold‚ C. R. & Graham‚ M. V. (2003). Clinical guidelines in family practice. Gainesville‚ Fl. Barmarre Books
Premium Dental caries Dentistry
Brian Thomason Unit 1 Homework MAN 5066-1 Managerial Ethics Professor Terrell Merck Corporation and the continued sale of Vioxx 1‚ What would be your view of what Merck has done: economically‚ legally‚ and ethically? Assume that all this has occurred before September 2004‚ when the senior executives at Merck removed Vioxx from the market‚ and while the risks of Vioxx were still not public knowledge. Would you approve‚ or disapprove‚ of the continued sale of the drug by your firm? I think
Premium Drugs Business ethics The Sale
balance‚ do you think Merck is an ethical and socially responsible company? Why or why not? How about Pfizer? In my opinion‚ Merck is not an ethical and socially responsible company with introducing Vioxx into pharmaceutical market. Before the Vioxx approval by FDA‚ scientists from University of Pennsylvania found that the drug could bring some serious results such as cardiovascular‚ and there were many serious cardiovascular problems during testing on patients. However‚ Merck ignored these negative
Premium Pharmaceutical industry Pharmacology Clinical trial
to balding men? Do you concentrate on targeting physicians? How about attempting to influence the wives or barbers of balding men? All these issues and more faced Tom Casola‚ who in 1997 was heading the Propecia marketing effort for the drug maker Merck & Co. The case was discussed by audience members at the 5th Annual Alumni Healthcare Conference on November 6‚ 2004; HBS assistant professor Marta Wosinska led the conversation. The Propecia launch came at a time of regulatory change‚ which made advertising
Premium Pharmacology Physician Marketing
CASE #2 BRAZIL: LEADING THE BRICS? ECNM 649 PROFESSOR ROBERT A COSCARELLO CHEN WANG ( CHERRY ) 11/02/2014 As of the date of the case and as explained in the case: is Brazil leading the BRICs? Please explain and defend your position. (We will discuss more recent data in class if time.) From the case I can see that for the past decade‚ Brazil has experienced greater integration into the global economy which has been characterized by significant growth in economy and reinforcement of the country
Premium Brazil Investment World Trade Organization
Jonathan Klein MN 305 Donna Trent June 29th‚ 2010 Starbucks Sourcing Problems: Trying to Find a way to Protect the Environment while maintaining a high quality coffee bean Starbucks Coffee Corporation is facing some strategic decisions on its current policy with regard to partnering with NGOs. Starbucks has a long history of social involvement. “CSR originated in 1994 as the Environmental Affairs Department with a budget of $50‚000; by 2002‚ the 14-member department had a budget of 6 million
Premium Coffee Fair trade
and customers play valuable roles in contributing to the profit making organization. If the organization ignores customer’s desires‚ customers will no longer actively want to purchase from the organization. In a case such as Merck and Co‚ Friedman would recommend that Merck not try to cure river blindness. The decision would not be profitable and would not be in the shareholder’s
Premium Stakeholder Profit Shareholder
returns. The debate started at a critical time for Merck & Co.; when patents on some of its main drugs were expiring and the drug stood as the product that would maintain profits in the
Premium Pharmacology Pharmaceutical drug Drug
through success in the field of Head and neck Cancer drug. They still had to get their phase 3 trial done (which looks like a market norm‚ though not a legal requirement). Erbitux which was developed by Imclone Systems in US had granted license to Merck to distribute the drug to India. Erbitux had already done 3 phase trial and they have got approval from European and US Drug agencies. They still not have received the approval from India drug authority (DGCI). But the same was expected soon. 1)
Premium Marketing Oncology Pharmacy
this virus. According to the Center for Disease Control‚ out of the 20 million Americans suffering from HPV each year‚ at least 33‚300 cancer cases first root from HPV ("HPV-Associated Cancers Statistics‚” par.1). These alarming statistics prompted Merck to release the first vaccine that could protect against the transmission of HPV in June 2006‚ called Gardasil. The release and availability of this vaccine
Premium Human papillomavirus HPV vaccine Cervical cancer